Skip to main content
Log in

Fibrillation cycle length predicts cardiovascular events in patients with long-standing persistent atrial fibrillation

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Background

Atrial fibrillation (AF) is associated with an increased risk of heart failure (HF), stroke, and death. Although fibrillation cycle length (FCL) is used as a surrogate for atrial refractoriness, its impact on outcomes remains unclear. This study aimed to identify predictors of cardiovascular events, including FCL, in patients with long-standing persistent AF.

Methods

The study included 190 consecutive patients with long-standing persistent AF (mean age 74 years, 74% male). Patients with valvular AF or hemodialysis-dependent end-stage renal disease and those on anti-arrhythmic drugs were excluded. The primary composite outcome was occurrence of cardiovascular events (myocardial infarction, HF), cerebrovascular events (stroke, transient ischemic attack), and all-cause death. FCL was calculated by fast Fourier transformation analysis of fibrillation waves in the surface electrocardiogram.

Results

Over a median follow-up of 2.6 years, the primary outcome occurred in 31 patients (cardiovascular events, n = 18; cerebrovascular events, n = 8; all-cause death, n = 5). In multivariate analysis, longer FCL and history of HF were independent predictors of these outcomes. In a Cox proportional hazards model adjusted for age, sex, and history of HF, patients with an FCL > 160 ms (cut-off determined by receiver-operating characteristic curve analysis) were at increased risk of the outcome (hazard ratio 12.9; 95% confidence interval 4.99–44.10; p < 0.001).

Conclusions

FCL was independently associated with cardiovascular outcomes in patients with long-standing persistent AF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Kirchhof P, Camm AJ, Goette A, Brandes A, Eckardt L, Elvan A, Fetsch T, van Gelder IC, Haase D, Haegeli LM, Hamann F, Heidbüchel H, Hindricks G, Kautzner J, Kuck KH, Mont L, Ng GA, Rekosz J, Schoen N, Schotten U, Suling A, Taggeselle J, Themistoclakis S, Vettorazzi E, Vardas P, Wegscheider K, Willems S, Breithardt GHJGMC (2020) Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med 383:1305–1316

    Article  Google Scholar 

  2. Marijon E, Le Heuzey JY, Connolly S, Yang S, Pogue J, Brueckmann M, Eikelboom J, Themeles E, Ezekowitz M, Wallentin L, Yusuf S (2013) Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study. Circulation 128:2192–2201

    Article  CAS  Google Scholar 

  3. Packer DL, Mark DB, Robb RA, Monahan KH, Bahnson TD, Poole JE, Noseworthy PA, Rosenberg YD, Jeffries N, Mitchell LB, Flaker GC, Pokushalov E, Romanov A, Bunch TJ, Noelker G, Ardashev A, Revishvili A, Wilber DJ, Cappato R, Kuck KH, Hindricks G, Davies DW, Kowey PR, Naccarelli GV, Reiffel JA, Piccini JP, Silverstein AP, Al-Khalidi HR, Lee KL (2019) Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA 321:1261–1274

    Article  CAS  Google Scholar 

  4. Staerk L, Sherer JA, Ko D, Benjamin EJ, Helm RH (2017) Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes. Circ Res 120:1501–1517

    Article  CAS  Google Scholar 

  5. Soliman EZ, Safford MM, Muntner P, Khodneva Y, Dawood FZ, Zakai NA, Thacker EL, Judd S, Howard VJ, Howard G, Herrington DM, Cushman M (2014) Trial fibrillation and the risk of myocardial infarction. JAMA Intern Med 174:107–114

    Article  Google Scholar 

  6. Chiang CE, Naditch-Brûlé L, Murin J, Goethals M, Inoue H, O’Neill J, Silva-Cardoso J, Zharinov O, Gamra H, Alam S, Ponikowski P, Lewalter T, Rosenqvist M, Steg PG (2012) Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: insight from the real-life global survey evaluating patients with atrial fibrillation international registry. Circ Arrhythm Electrophysiol 5:632–639

    Article  Google Scholar 

  7. King JB, Azadani PN, Suksaranjit P, Bress AP, Witt DM, Han FT, Chelu MG, Silver MA, Biskupiak J, Wilson BD, Morris AK, Kholmovski EG, Marrouche N (2017) Left atrial fibrosis and risk of cerebrovascular and cardiovascular events in patients with atrial fibrillation. J Am Coll Cardiol 70:1311–1321

    Article  Google Scholar 

  8. Rohla M, Weiss TW, Pecen L, Patti G, Siller-Matula JM, Schnabel RB, Schilling R, Kotecha D, Lucerna M, Huber K, Caterina RD, Kirchhof P (2019) Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events—European Registry in Atrial Fibrillation (PREFER in AF). BMJ Open 9:e022478

    Article  Google Scholar 

  9. Jadidi AS, Cochet H, Shah AJ, Kim SJ, Duncan E, Miyazaki S, Sermesant N, Lehrmann H, Lederlin M, Linton N, Forclaz A, Nault I, Rivard L, Wright M, Liu X, Scherr D, Wilton SB, Roten L, Pascale P, Derval N, Sacher F, Knecht S, Keyl C, Hocini M, Montaudon M, Laurent F, Haïssaguerre M, Jaïs P (2013) Inverse relationship between fractionated electrograms and atrial fibrosis in persistent atrial fibrillation: combined magnetic resonance imaging and high-density mapping. J Am Coll Cardiol 62:802–812

    Article  Google Scholar 

  10. Oikawa J, Niwano S, Fukaya H, Nakamura H, Igarashi T, Fujiishi T, Ishizue N, Yoshizawa T, Satoh A, Kishihara J, Murakami M, Ako J (2017) Novel scoring system for distinction between paroxysmal and non-paroxysmal atrial fibrillation. Circ J 81:788–793

    Article  CAS  Google Scholar 

  11. Sasaki T, Niwano S, Sasaki S, Imaki R, Yuge M, Hirasawa S, Satoh D, Moriguchi M, Fujiki A, Izumi T (2006) Long-term follow-up of changes in fibrillation waves in patients with persistent atrial fibrillation: spectral analysis of surface ECG. Circ J 70:169–173

    Article  Google Scholar 

  12. Fujiki A, Nagasawa H, Sakabe M, Sakurai K, Nishida K, Inoue H (2001) Spectral characteristics of human atrial fibrillation waves of the right atrial free wall with respect to the duration of atrial fibrillation and effect of class I anti-arrhythmic drugs. Jpn Circ J 65:1047–1051

    Article  CAS  Google Scholar 

  13. Yuen HC, Roh SY, Lee DI, Ahn J, Kim DH, Shim J, Park SW, Kim YH (2015) Atrial fibrillation cycle length as a predictor for the extent of substrate ablation. Europace 17:1391–1401

    Article  Google Scholar 

  14. Drewitz I, Willems S, Salukhe TV, Steven D, Hoffmann BA, Servatius H, Bock K, Aydin MA, Wegscheider K, Meinertz T, Rostock T (2010) Atrial fibrillation cycle length is a sole independent predictor of a substrate for consecutive arrhythmias in patients with persistent atrial fibrillation. Circ Arrhythm Electrophysiol 3:351–360

    Article  Google Scholar 

  15. Akkaya M, Higuchi K, Koopmann M, Damal K, Burgon NS, Kholmovski E, McGann C, Marrouche N (2013) Higher degree of left atrial structural remodeling in patients with atrial fibrillation and left ventricular systolic dysfunction. J Cardiovasc Electrophysiol 24:485–491

    Article  Google Scholar 

  16. Taniguchi N, Miyasaka Y, Suwa Y, Harada S, Nakai E, Shiojima I (2020) Heart failure in atrial fibrillation—an update on clinical and echocardiographic implications. Circ J 84:1212–1217

    Article  Google Scholar 

  17. Hocini M, Nault I, Wright M, Veenhuyzen G, Narayan SM, Jaïs P, Lim KT, Knecht S, Matsuo S, Forclaz A, Miyazaki S, Jadidi A, O’Neill MD, Sacher F, Clémenty J, Haïssaguerre M (2010) Disparate evolution of right and left atrial rate during ablation of long-lasting persistent atrial fibrillation. J Am Coll Cardiol 55:1007–1016

    Article  Google Scholar 

  18. Ivanov A, Mohamed A, Asfour A, Ho J, Khan SA, Chen O, Klem I, Ramasubbu K, Brener SJ, Heitner JF (2017) Right atrial volume by cardiovascular magnetic resonance predicts mortality in patients with heart failure with reduced ejection fraction. PLoS ONE 12:e0173245

    Article  Google Scholar 

  19. Sallach JA, Tang WHW, Borowski AG, Tong W, Porter T, Martin MG, Jasper SE, Shrestha K, Troughton RW, Klein AL (2009) Right atrial volume index in chronic systolic heart failure and prognosis. JACC Cardiovasc Imaging 2:527–534

    Article  Google Scholar 

  20. Xie E, Yu R, Ambale-Venkatesh B, Bakhshi H, Heckbert SR, Soliman EZ, Bluemke DA, Kawut SM, Wu CO, Nazarian S, Lima JAC (2020) Association of right atrial structure with incident atrial fibrillation: a longitudinal cohort cardiovascular magnetic resonance study from the Multi-Ethnic Study of Atherosclerosis (MESA). J Cardiovasc Magn Reson 22:36

    Article  Google Scholar 

  21. Luong C, Thompson DJS, Bennett M, Gin K, Jue J, Barnes ME, Colley P, Tsang TSM (2015) Right atrial volume is superior to left atrial volume for prediction of atrial fibrillation recurrence after direct current cardioversion. Can J Cardiol 31:29–35

    Article  Google Scholar 

Download references

Acknowledgements

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hironori Nakamura.

Ethics declarations

Conflict of interest

Junya Ako is a member of Circulation Journal’s editorial team.

Ethics approval

This study was approved by the ethics committee of Kitasato University Hospital (approval number B 11-46).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nakamura, H., Niwano, S., Fukaya, H. et al. Fibrillation cycle length predicts cardiovascular events in patients with long-standing persistent atrial fibrillation. Heart Vessels 37, 1027–1033 (2022). https://doi.org/10.1007/s00380-021-01993-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-021-01993-x

Keywords

Navigation